Extensive diversification is a common feature of Pseudomonas aeruginosa populations during respiratory infections in cystic fibrosis

Journal of Cystic Fibrosis

Volumn 12, Issue 6, 2013, Pages 790-793

  Ashish, Abdul ^a   Paterson, Steve ^b   Mowat, Eilidh ^b   Fothergill, Joanne L ^b   Walshaw, Martin J ^a   Winstanley, Craig ^b  

^a LIVERPOOL HEART AND CHEST HOSPITAL   (United Kingdom)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Cystic fibrosis; Population biology; Pseudomonas aeruginosa

Indexed keywords

CEFTAZIDIME; CIPROFLOXACIN; COLISTIN; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; TOBRAMYCIN;

ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; AUXOTROPHY; BACTERIAL COLONIZATION; BACTERIAL VIRULENCE; BACTERIUM ISOLATION; CLINICAL ARTICLE; CYSTIC FIBROSIS; FEMALE; HUMAN; MALE; MICROBIOLOGICAL EXAMINATION; PHENOTYPIC VARIATION; PSEUDOMONAS AERUGINOSA; RESPIRATORY TRACT INFECTION; SPUTUM CULTURE;

CYSTIC FIBROSIS; POPULATION BIOLOGY; PSEUDOMONAS AERUGINOSA;

ADULT; CYSTIC FIBROSIS; FEMALE; HUMANS; LUNG; MALE; PHENOTYPE; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; SPUTUM; YOUNG ADULT;

EID: 84888018473     PISSN: 15691993     EISSN: 18735010     Source Type: Journal    
DOI: 10.1016/j.jcf.2013.04.003     Document Type: Article

References (16)

1. Foweraker J.E., Laughton C.R., Brown D.F., Bilton D. Phenotypic variability of Pseudomonas aeruginosa in sputa from patients with acute infective exacerbation of cystic fibrosis and its impact on the validity of antimicrobial susceptibility testing. J Antimicrob Chemother 2005, 55:921-927.
2. Fothergill J.L., Mowat E., Ledson M.J., Walshaw M.J., Winstanley C. Fluctuations in phenotypes and genotypes within populations of Pseudomonas aeruginosa in the cystic fibrosis lung during pulmonary exacerbations. J Med Microbiol 2010, 59:472-481.
3. Mowat E., Paterson S., Fothergill J.L., Wright E.A., Ledson M.J, Walshaw M.J., et al. Pseudomonas aeruginosa population diversity and turnover in cystic fibrosis chronic infections. Am J Respir Crit Care Med 2011, 183:1674-1679.
4. Winstanley C., Langille M.G.I., Fothergill J.L., Kukavica-Ibrulj I., Paradis-Bleau C., Sanschagrin F., et al. Newly introduced genomic prophage islands are critical determinants of in vivo competitiveness in the Liverpool Epidemic Strain of Pseudomonas aeruginosa. Genome Res 2009, 19:12-23.
5. Fothergill J.L., Walshaw M.J., Winstanley C. Transmissible strains of Pseudomonas aeruginosa in cystic fibrosis lung infections. Eur Respir J 2012.
6. Smith E.E., Buckley D.G., Wu Z., Saenphimmachak C., Hoffman L.R., D'Argenio D.A., et al. Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients. Proc Natl Acad Sci U S A 2006, 103:8487-8492.
7. Bragonzi A., Paroni M., Nonis A., Cramer N., Montanari S., Rejman J., et al. Pseudomonas aeruginosa microevolution during cystic fibrosis lung infection establishes clones with adapted virulence. Am J Respir Crit Care Med 2009, 180:138-145.
8. Huse H.K., Kwon T., Zlosnik J.E., Speert D.P., Marcotte E.M., Whiteley M. Parallel evolution in Pseudomonas aeruginosa over 39,000 generations in vivo. mBio 2010, 1.
9. Cramer N., Klockgether J., Wrasman K., Schmidt M., Davenport C.F., Tummler B. Microevolution of the major common Pseudomonas aeruginosa clones C and PA14 in cystic fibrosis lungs. Environ Microbiol 2011, 13:1690-1704.
10. Yang L., Jelsbak L., Marvig R.L., Damkiaer S., Workman C.T., Rau M.H., et al. Evolutionary dynamics of bacteria in a human host environment. Proc Natl Acad Sci U S A 2011, 108:7481-7486.
11. Wiehlmann L., Wagner G., Cramer N., Siebert B., Gudowius P., Morales G., et al. Population structure of Pseudomonas aeruginosa. Proc Natl Acad Sci U S A 2007, 104:8101-8106.
12. Fothergill J.L., Upton A.L., Pitt T.L., Hart C.A., Winstanley C. Diagnostic multiplex PCR assay for the identification of the Liverpool, Midlands 1 and Manchester CF epidemic strains of Pseudomonas aeruginosa. J Cyst Fibros 2008, 7:258-261.
13. Goss C.H., Burns J.L. Exacerbations in cystic fibrosis. 1: epidemiology and pathogenesis. Thorax 2007, 62:360-367.
14. De Vos D., Lim A., Pirnay J.P., Struelens M., Vandenvelde C., Duinslaeger L., et al. Direct detection and identification of Pseudomonas aeruginosa in clinical samples such as skin biopsy specimens and expectorations by multiplex PCR based on two outer membrane lipoprotein genes, oprI and oprL. J Clin Microbiol 1997, 35:1295-1299.
15. Kenna D.T., Doherty C.J., Foweraker J., Macaskill L., Barcus V.A., Govan J.R.W. Hypermutability in environmental Pseudomonas aeruginosa and in populations causing pulmonary infection in individuals with cystic fibrosis. Microbiology 2007, 153:1852-1859.
16. Chung J.C., Becq J., Fraser L., Schulz-Trieglaff O., Bond N.J., Foweraker J., et al. Genomic variation among contemporary Pseudomonas aeruginosa isolates from chronically infected cystic fibrosis patients. J Bacteriol 2012, 194:4857-4866.